- About us
- A new Institute dedicated to combating leukemia
- Scientific and medical program
- History of Hematology on the Saint-Louis Campus
- The Leukemia Institute’s governance
- The Leukemia Institute’s member sites
- Press
- Contact us
- Our news
- Launch of our podcast « Guérir les globules »
- Launch of a photographic residency “Through the eyes of the patient and the caregiver”
- Winners of the internal call for projects 2026
- Perspectives in the treatment of aplastic anemia
- The 2025 Olga Sain Prize
- Support us
- Make a donation
- A sporting challenge in memory of Nicolas, who passed away from leukemia
- Launch concert of the Leukemia Institute
- Join us
- You are
- Patients and relatives
- To receive care and support
- Become an expert patient
- Discover the Leukemia Institute
- A new Institute dedicated to combating leukemia
- Launch of our podcast « Guérir les globules »
- Contact us
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Cancer treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Saint-Louis Hospital – Department of adult hematology
- Saint-Louis Hospital – Hematology Transplant Unit
- Saint-Louis Hospital – Department of Pharmacology and Clinical Investigations
- Saint-Louis Hospital – Adolescent and Young Adult Unit
- Saint-Louis Hospital – Outpatient Hemato-oncogenetics Unit
- Saint-Louis Hospital – Department of senior hematology
- Robert-Debré Hospital – Department of pediatric hematology and immunology
- Necker Hospital – Department of Adult Hematology
- Cochin–Port Royal Hospital – Department of clinical hematology
- Avicenne Hospital – Department of clinical hematology and cell therapy
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Cancer treatments
- Supportive Care
- Psychological Support
- Launch of our podcast « Guérir les globules »
- Research
- Our research teams
- Hugues de Thé’s team – Molecular pathology
- Raphaël Itzykson’s team – Functional precision medicine for leukemia
- Michaela Fontenay’s team – Normal and pathological hematopoiesis
- Françoise Pflumio’s team – Niche, Cancer, and Radiation in Hematopoiesis
- Sylvie Méléard’s team – Population Evolution and Interaction Particle Systems
- David Michonneau’s team – Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Lina Benajiba’s team – Identification and targeting of extrinsic regulators of myeloid malignancies
- Karl Balabanian’s team – Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Alexandre Puissant’s team – Molecular Mechanisms of Acute Myeloid Leukemia Development
- Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Diana Passaro’s team – Leukemia & Niche Dynamics
- Camille Lobry’s team – Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Jean Soulier’s team – Stem cell dysfunction and secondary AML
- Sylvie Chevret’s team – Biostatistics and clinical epidemiology
- Emmanuelle Clappier’s team – Genomic basis of B-cell acute leukemia
- Vahid Asnafi’s team – Normal and Pathological Lymphoid Differenciation
- Matthieu Duchmann’s team – Leukemia evolution and plasticity [LEAP]
- Kevin Rouault-Pierre’s team – Stress Integration in Normal and Malignant Hematopoietic Stem Cells
- Our technological platforms
- Our clinical research
Accueil A sporting challenge in memory of Nicolas, who passed away from leukemiaA sporting challenge in memory of Nicolas, who passed away from leukemia
...Emmanuel Gourbesville takes on an extraordinary challenge to raise awareness and support the fight against leukemia
To pay tribute to his friend and physiotherapist Nicolas Caquineau, who passed away from leukemia at the age of 30, Emmanuel Gourbesville will take on the APEX in June 2028: the first extreme triathlon linking the summit of Mont Blanc to the Mediterranean Sea.
An adventure to keep Nicolas’s memory alive, raise awareness of leukemia, and raise funds for research.
His sporting career includes 30 XXL triathlons, 25 ultra-trail races and 15 marathons.
Here are some of his most notable achievements:
-
Tor des Glaciers: 450 km trail race with 35,000 m of elevation gain
-
French Ultra-Triathlon Championship for Internal Security Forces — 4th place
-
Paris Marathon — 2:44
-
Ironman World Championship, Nice
Key figures
3consecutive disciplines
618kilometres to cover
18000metres of elevation gain
Your donation helps drive research forward
Your donation will directly fund research at the Institut de la Leucémie Paris Saint-Louis
to develop more targeted and effective treatments
and improve patient care.Who was Nicolas Caquineau?
“A sportsman at heart, Nicolas loved pushing his limits and inspired those around him to do the same.
This extreme adventure carries on his fight against leukemia.”Nicolas’s family
The APEX 2028 route
Stage 1: Trail running and mountaineering – 110 km
Starting from the summit of Mont Blanc, at an altitude of 4,806 m, then descending to the shores of Lake Annecy.
Stage 2: Swimming – 18 km
Swimming the entire length of Lake Annecy.
Stage 3: Cycling – 500 km
From Lake Annecy to Mont Ventoux, then on to the Mediterranean Sea.
Stage 1: Trail running and mountaineering – 110 km
Starting from the summit of Mont Blanc, at an altitude of 4,806 m, then descending to the shores of Lake Annecy.
Stage 2: Swimming – 18 km
Swimming the entire length of Lake Annecy.
Stage 3: Cycling – 500 km
From Lake Annecy to Mont Ventoux, then on to the Mediterranean Sea.
Testimonial from Emmanuel Gourbesville, endurance athlete
“Leukemia affects around 10,000 people in France every year, at every stage of life. Yet it receives little public attention. A challenge like APEX draws attention: it will be followed by athletes, the media and mountain enthusiasts, reaching far beyond the circle of those who know the disease.
Six hundred kilometres of effort, sleepless nights and moments of doubt: APEX demands perseverance, whatever happens. This is also what patients and their loved ones experience every day as they face leukemia. This challenge is dedicated to them.”“APEX is an exceptionally demanding challenge, combining trail running, swimming and cycling over more than 600 km. I had been hesitating about taking it on, while Nicolas, who was my physiotherapist, was encouraging me to do it. In July 2026, he was taken by an aggressive form of leukemia at just 30 years old. His passing deeply affected me and made me decide to take the plunge. You should never put your dreams off until later.”
All funds raised will be donated to the Leukemia Institute Paris Saint-Louis, a University Hospital Institute dedicated to leukemia research and innovation.
Established in 2023 as part of the France 2030 investment plan, it brings together teams from several leading hospitals and institutions within a unique European network. Its goal: to cure leukemia at every stage of life.”“My name is Emmanuel Gourbesville. I am married and have three children. For more than twenty years, I have been practising endurance sports in the great outdoors, with over 150 races under my belt. I build up to each challenge step by step, prioritising gradual progression and risk management. I am preparing for APEX with the same level of rigour.”Stay up to date by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To receive care and support
- A new Institute dedicated to combating leukemia